NXL (Nexalin Technology) Change In Other Working Capital : $-0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Nexalin Technology Change In Other Working Capital?

Nexalin Technology's Change In Other Working Capital for the quarter that ended in Mar. 2025 was $-0.00 Mil. It means Nexalin Technology's Other Working Capital declined by $0.00 Mil from Dec. 2024 to Mar. 2025 .

Nexalin Technology's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $-0.00 Mil. It means Nexalin Technology's Other Working Capital declined by $0.00 Mil from Dec. 2023 to Dec. 2024 .

Nexalin Technology Change In Other Working Capital Historical Data

The historical data trend for Nexalin Technology's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexalin Technology Change In Other Working Capital Chart

Nexalin Technology Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

-0.03

0.09

-0.18

-0.05

Nexalin Technology Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Other Working Capital	Get a 7-Day Free Trial													-0.01	-0.06	0.05	-	-

Nexalin Technology Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

Nexalin Technology Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Nexalin Technology's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Nexalin Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nexalin Technology Inc (NAS:NXL) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

1776 Yorktown, Suite 550, Houston, TX, USA, 77056

Website

https://www.nexalin.com

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Executives

David Owens	director, officer: Chief Medical Officer	4545 HARRIS TRAIL NW, ATLANTA GA 30327
Marilyn Elson	10 percent owner, officer: Ms. Elson serves as CFO	32 CAMLET COURT, ROSELAND NJ 07068
Rick Morad	director	6331 CHAGRIN RIVER ROAD, BENTLEYVILLE OH 44022
Mark White	director, officer: President/CEO	1776 YORKTOWN STREET, SUITE 550, HOUSTON TX 77056
Alan Kazden	director	3435 CONSUELO DRIVE, CALABASAS CA 91302
Leonard Osser	other: Spouse
Ben Hu	director	7021 EDGERTON ROAD, NORTH ROYALTON OH 44133